Peptide-Oligonucleotide Conjugates (POCs) Synthesis

Introduction The Oligonucleotide Capacity Challenge highlights the growing industrial mismatch between the rapidly increasing global therapeutic demand for small interfering […]

Introduction Oligonucleotide Purification Explained focuses on assessing Anion-Exchange Chromatography (AEX) and Ion-Pair Reversed-Phase Chromatography (IP-RP), the two primary chromatographic techniques

Introduction: Peptide-Oligonucleotide Conjugation Optimization is the systematic tuning of chemistry, reaction conditions, monitoring and purification so that a peptide and

Introduction Quality control of Oligonucleotide Starting Materials involves systematic analytical characterization, impurity quantification, and physical validation of phosphoramidites and functionalized

Introduction Therapeutic oligonucleotide manufacturing depends on Phosphoramidite Solid-Phase Synthesis to assemble custom single-stranded and double-stranded nucleic acid sequences at scales

Introduction: Peptide-Oligonucleotide Conjugation Yield Optimization is the systematic improvement of the reaction and recovery processes used to make a peptide-linked

Introduction: Peptide-oligonucleotide conjugates for oncology are engineered molecules in which a peptide is chemically linked to an oligonucleotide designed to

Introduction: The ICH guidelines for peptide-oligonucleotide conjugates give developers a scientifically justified framework, even though no single ICH guideline is

Introduction Developing robust Reference Standards and Analytical Method Validation strategies for peptide-oligonucleotide conjugates (POCs) is critical for establishing biopharmaceutical identity,

Introduction: GMP Manufacturing of Peptide-Oligonucleotide Conjugates requires a manufacturing strategy that accounts for the distinct chemical and analytical characteristics of